Please wait while you are being redirected ...
This site is best viewed with Internet Explorer version 8 or greater. Check your browser compatibility mode if you are using Internet Explorer version 8 or greater.
Log In / Register
Newsletter Sign Up
Newsletter Sign Up
Sign up for IHI's Email Services
Improving Health and Health Care Worldwide
Engage with IHI
Vision, Mission, Values
Science of Improvement
How to Get Involved
In the News
All Topics A-Z
Quality, Cost, and Value
Triple Aim for Populations
IHI National Forum
IHI Patient Safety Congress
WIHI Audio Program
Certified Professional in Patient Safety (CPPS)
IHI Open School
How to Improve
IHI White Papers
Audio and Video
Engage with IHI
Engage with IHI Overview
46 items found
Use SHIFT+ENTER to open the menu (new window).
Addressing the Opioid Crisis in the United States
This IHI Innovation Report discusses key reasons why current efforts to reduce prescription opioid use and misuse in the US have thus far been largely ineffective in stemming the crisis; highlights gaps in current efforts that underscore the need for a coordinated and collaborative community-wide approach; identifies four primary drivers to reduce opioid use; and proposes a high-level construct for a system approach at the community level to address the US opioid crisis.
WIHI: Nurturing Trust: Addiction and Maternal and Newborn Health
June 2, 2016 | Addiction is always a complex challenge, but when a woman using substances is pregnant, suddenly two lives are at stake.
Measures: Prevent Harm from High-Alert Medications
Care teams should measure each of the key interventions recommended in the How-to Guide: Prevent Harm from High-Alert Medications.
Passport Exclusive: Providing Reliable Perinatal Care by Using Clinical Bundles
In this video, Sue Leavitt-Gullo, MS, RN, Director for IHI, reviews providing reliable perinatal care through usings clinically proven bundles.
Anticoagulant Toolkit: Reducing Adverse Drug Events
ADEs associated with anticoagulants can be reduced by implementing recognized safe practices in high-risk areas, redesigning care processes, partnering with patients and families, and maximizing communications within and across the care continuum.
How-to Guide: Prevent Harm from High-Alert Medications — Rural Hospitals Supplement
This How-to Guide specifically tailored for rural hospitals describes key evidence-based care components for preventing harm from high-alert medications, describes how to implement these interventions, and recommends measures to gauge improvement.
Annotated Bibliography for Preventing Harm from High-Alert Medications
This annotated bibliography presents selected literature for preventing harm from high-alert medications.
How-to Guide: Prevent Harm from High-Alert Medications — Pediatric Supplement
This How-to Guide specifically tailored for pediatrics describes key evidence-based care components for preventing harm from high-alert medications, describes how to implement these interventions, and recommends measures to gauge improvement.
How-to Guide: Prevent Harm from High-Alert Medications
This How-to Guide describes key evidence-based care components for preventing harm from high-alert medications, describes how to implement these interventions, and recommends measures to gauge improvement.
Guide to Coumadin (Warfarin) Therapy
An educational and reference tool for patients that provides important information about anticoagulation therapy for patients who take warfarin, and answers many common questions about the drug.
Warfarin-Herbal Interactions List
A reference for prescribers, nurses, and pharmacists listing herbal agents known to interact with warfarin and the types of interactions to expect.
High-Alert Medications Require Heightened Vigilance
The classification "high-alert medication" is helping those concerned with patient safety to draw attention to the risks associated with certain drugs, even when used as intended, and the steps that can be taken to prevent injury.
Proactive Approaches to Reduce Harm from High-Alert Medications
In this 2007 IHI National Forum workshop presentation, two medication safety experts report on efforts at their hospitals to prevent medication errors.
OSF St. James–John W. Albrecht Medical Center: Where Patients Receive Focused Outpatient Medication Management
At OSF St. James, the anticoagulation clinic helps patients manage their high-alert medication a contrast to the more typical care model in which patients are managed by their primary care provider.
High-Alert Adverse Drug Events per 1,000 Doses
The total number of ADEs related to a specific high-alert drug or class identified in a sample of patient records, divided by the total number of doses of the high-alert drug or class administered to those patients. Multiply the result by 1,000.
Percent of Patients Receiving a Specific High-Alert Medication with a Related Adverse Drug Event
The total number of patients identified as having experienced any ADE related to a specific high-alert drug or class from a sample of patient records, divided by the total number of records in the sample. Multiply the result by 100 to express as a percentage.
Reduce Adverse Drug Events Involving Chemotherapy
Use extra safety measures with chemotherapy medications to prevent adverse drug events (ADEs), which can be extremely serious due to the toxicity of these drugs.
Reduce Adverse Drug Events Involving Narcotics and Sedatives
Careful monitoring and management of narcotics and sedatives can help prevent harm, especially from overdoses.
Reduce Adverse Drug Events Involving Insulin
Coordinate care processes and use standardized tools when caring for patients on insulin to reduce the risk of adverse drug events (ADEs).
Allow Pharmacists to Manage an Anticoagulant Service
Allow pharmacists to manage an anticoagulation service to improve efficiency and help prevent adverse drug events.
Eliminate the Use of Heparin Solution with Arterial Lines
Eliminate the use of heparin solution in the pressurized bags attached to arterial lines, a practice known to cause accidental administration of heparin doses that can lead to adverse drug events.
Use Low Molecular Weight Heparin (LMWH)
Administration of low molecular weight heparin (LMWH) has a lower adverse drug event (ADE) profile than regular heparin and presents significantly less risk of error because it is simpler to use.
Use Anticoagulation Flowsheets
Recording all of a patient’s anticoagulation information on a flowsheet makes anticoagulation therapy easier for the staff to administer and may reduce the risk of errors.
Adjust Anticoagulants with Thrombolytic and G2b/3A Inhibitors
A system that reminds prescribers to take into account thrombolytic and G2b/3A inhibitors as they set anticoagulant doses can help reduce the risk of bleeding or other adverse drug events.
Standardize International Normalized Ratio Testing Equipment
Using one standard type of International Normalized Ratio (INR) testing equipment throughout your organization to set anticoagulant doses will help minimize potentially hazardous variation in results.